X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32821) 32821
Newsletter (3704) 3704
Publication (2555) 2555
Newspaper Article (626) 626
Book Review (568) 568
Magazine Article (236) 236
Book Chapter (75) 75
Trade Publication Article (31) 31
Conference Proceeding (23) 23
Dissertation (20) 20
Book / eBook (19) 19
Transcript (18) 18
Web Resource (6) 6
Government Document (5) 5
Data Set (3) 3
Paper (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
postmenopausal women (28566) 28566
humans (23851) 23851
female (21416) 21416
middle aged (13839) 13839
index medicus (13390) 13390
aged (11426) 11426
osteoporosis (10805) 10805
risk factors (7016) 7016
breast cancer (6968) 6968
research (6954) 6954
health aspects (6712) 6712
adult (6621) 6621
endocrinology & metabolism (6269) 6269
women (5736) 5736
male (5578) 5578
care and treatment (5515) 5515
cancer (5233) 5233
menopause (4756) 4756
oncology (4734) 4734
bone density (4208) 4208
aged, 80 and over (4181) 4181
estrogen (4003) 4003
fractures (3896) 3896
risk (3872) 3872
obstetrics & gynecology (3868) 3868
bone-mineral density (3665) 3665
hormone replacement therapy (3312) 3312
analysis (3225) 3225
postmenopause (3170) 3170
tamoxifen (2990) 2990
medicine & public health (2918) 2918
prevention (2787) 2787
bones (2706) 2706
breast neoplasms - drug therapy (2654) 2654
medicine, general & internal (2606) 2606
density (2596) 2596
osteoporosis, postmenopausal - drug therapy (2564) 2564
postmenopausal osteoporosis (2538) 2538
treatment outcome (2504) 2504
drug therapy (2450) 2450
orthopedics (2398) 2398
oncology, experimental (2331) 2331
bone mineral density (2303) 2303
therapy (2261) 2261
bone density - drug effects (2253) 2253
diagnosis (2166) 2166
bone density conservation agents - therapeutic use (2075) 2075
animals (2059) 2059
rheumatology (2017) 2017
mineral density (1973) 1973
prospective studies (1881) 1881
medical research (1750) 1750
physiological aspects (1720) 1720
endocrinology (1718) 1718
hip fracture (1715) 1715
hormone therapy (1666) 1666
randomized-trial (1661) 1661
womens health (1654) 1654
absorptiometry, photon (1635) 1635
reports (1629) 1629
alendronate (1624) 1624
body mass index (1594) 1594
double-blind (1589) 1589
osteoporosis - drug therapy (1581) 1581
estrogen replacement therapy (1571) 1571
medicine (1549) 1549
pharmacology & pharmacy (1532) 1532
prevalence (1489) 1489
case-control studies (1476) 1476
breast neoplasms - pathology (1457) 1457
clinical trials (1451) 1451
randomized controlled-trial (1426) 1426
medicine, experimental (1402) 1402
osteoporosis, postmenopausal - complications (1376) 1376
follow-up studies (1368) 1368
mortality (1363) 1363
retrospective studies (1361) 1361
surgery (1356) 1356
risk-factors (1347) 1347
bisphosphonates (1346) 1346
cross-sectional studies (1346) 1346
internal medicine (1344) 1344
article (1325) 1325
vertebral fractures (1323) 1323
research article (1317) 1317
time factors (1306) 1306
risk assessment (1293) 1293
double-blind method (1286) 1286
prognosis (1272) 1272
vitamin d (1271) 1271
diphosphonates - therapeutic use (1267) 1267
breast-cancer (1252) 1252
age factors (1251) 1251
epidemiology (1247) 1247
bone density - physiology (1234) 1234
age (1232) 1232
obesity (1222) 1222
quality of life (1219) 1219
abridged index medicus (1218) 1218
osteoporosis, postmenopausal - prevention & control (1196) 1196
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
New College (Ivey) - Stacks (3) 3
Online Resources - Online (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36221) 36221
German (311) 311
French (221) 221
Spanish (197) 197
Japanese (70) 70
Polish (68) 68
Russian (65) 65
Turkish (51) 51
Italian (47) 47
Korean (43) 43
Chinese (36) 36
Portuguese (31) 31
Danish (21) 21
Hungarian (21) 21
Croatian (13) 13
Czech (13) 13
Dutch (11) 11
Swedish (10) 10
Norwegian (9) 9
Slovak (7) 7
Serbian (6) 6
Finnish (4) 4
Persian (4) 4
Romanian (4) 4
Slovenian (4) 4
Ukrainian (3) 3
Arabic (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Bulgarian (1) 1
Estonian (1) 1
Georgian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2018, Volume 167, Issue 3, pp. 607 - 614
Prospective information regarding the tolerability and efficacy of endocrine therapy (ET) alone and in combination with targeted agents in older patients in... 
Medicine & Public Health | Geriatric | Palbociclib | Ribociclib | Oncology | Breast cancer | Elderly | CDK4/6 inhibitor | PLACEBO | MULTICENTER | ANASTROZOLE | WOMEN | EXEMESTANE | ONCOLOGY | FULVESTRANT | LETROZOLE | PROGRESSION | POSTMENOPAUSAL PATIENTS | Care and treatment | Epidermal growth factor | Oncology, Experimental | Aged patients | Development and progression | Metastasis | Research | Cancer
Journal Article
Journal Article
Journal Article
Journal Article
Breast Cancer Research, ISSN 1465-5411, 07/2010, Volume 12, Issue 4, pp. R47 - R47
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 7, pp. 653 - 662
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 17, pp. 1299 - 1309
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2013, Volume 109, Issue 12, pp. 2959 - 2964
Background: ER+/HER2 - breast cancers have a proclivity for late recurrence. A personalised estimate of relapse risk after 5 years of endocrine treatment can... 
late relapse | TAMOXIFEN | RANDOMIZED-TRIAL | RISK | EndoPredict | AUSTRIAN BREAST | EXTENDED ADJUVANT THERAPY | endocrine therapy | ANASTROZOLE | POSITIVE BREAST-CANCER | ONCOLOGY | LETROZOLE | RECURRENCE | POSTMENOPAUSAL WOMEN | Triazoles - administration & dosage | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Neoplasm Recurrence, Local - drug therapy | Cell Growth Processes - physiology | Gene Expression Profiling | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Neoplasm Recurrence, Local - pathology | Nitriles - administration & dosage | Clinical Trials, Phase III as Topic | Neoplasm Metastasis | Antineoplastic Agents, Hormonal - therapeutic use | Female | Retrospective Studies | Cell Differentiation - physiology | Receptor, ErbB-2 - biosynthesis | Receptors, Estrogen - genetics | Neoplasm Recurrence, Local - metabolism | Signal Transduction | Antineoplastic Agents, Hormonal - administration & dosage | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Tamoxifen - therapeutic use | Receptors, Estrogen - biosynthesis | Neoplasm Recurrence, Local - genetics | Clinical Study
Journal Article
Journal Article